# [68Ga] NOTA-SGC8 in the Staging of Bladder Cancer

> **NCT06005116** · NA · UNKNOWN · sponsor: **RenJi Hospital** · enrollment: 64 (estimated)

## Conditions studied

- Bladder Cancer

## Interventions

- **RADIATION:** [68Ga]-NOTA-SGC8

## Key facts

- **NCT ID:** NCT06005116
- **Lead sponsor:** RenJi Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-15
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06005116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06005116, "[68Ga] NOTA-SGC8 in the Staging of Bladder Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06005116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*